help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2003-0296
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, X.
Right arrow Articles by McDonald, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, X.
Right arrow Articles by McDonald, J. M.
Endocrinology Vol. 144, No. 12 5545-5555
Copyright © 2003 by The Endocrine Society

Osteoclast Apoptosis: The Role of Fas in Vivo and in Vitro

Xiaojun Wu, Margaret A. McKenna, Xu Feng, Tim R. Nagy and Jay M. McDonald

Departments of Pathology (X.W., M.A.M., X.F., J.M.M.) and Nutrition Science (T.R.N.), University of Alabama at Birmingham, Birmingham, Alabama 35294; and Veterans Administration Medical Center (J.M.M.), Birmingham, Alabama 35233

Address all correspondence and requests for reprints to: Jay M. McDonald, Professor and Chair, Department of Pathology, Director, Center for Metabolic Bone Disease, University of Alabama at Birmingham, 509 Lyons Harrison Research Building, 1530 3rd Avenue South, Birmingham, Alabama 35294-0007. E-mail: mcdonald{at}path.uab.edu.

Both the number and the activity of osteoclasts are critical for maintaining normal bone turnover. The number is determined by rates of cell differentiation and death. Fas-mediated apoptosis is a dominant mechanism for apoptosis. Here, we show the presence of the Fas receptor on mouse, human, avian, and cultured RAW264.7 (murine) derived osteoclasts and the up-regulation of its expression during mouse osteoclast differentiation. Additionally, Fas is a fully functional death receptor in osteoclasts, and its signaling pathway is consistent with classical Fas signaling in other cell systems, involving mitochondrial release of cytochrome c and activation of caspases 3 and 9. This demonstration of Fas-mediated apoptosis in mature osteoclasts provides a new and potent mechanism for the regulation of osteoclast life span. The in vivo significance of Fas-mediated apoptosis in bone (osteoclasts) was demonstrated in aged Lpr and Gld mice, which have a dysfunctional immune system. Lpr mice, which have a defect in the Fas gene, have decreased bone mineral density, bone volume, trabecular thickness, and increased osteoclast number. Gld mice, which have a Fas ligand mutation, have a slight yet insignificant decrease in bone mineral density, but a highly significant increase in osteoclast number. Taken together, these data demonstrate that the Fas/Fas ligand system is important in the regulation of bone turnover and may represent a critical link between the immune system and bone remodeling in development and in various diseases.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
J. Lorenzo, M. Horowitz, and Y. Choi
Osteoimmunology: Interactions of the Bone and Immune System
Endocr. Rev., June 1, 2008; 29(4): 403 - 440.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Yang, W. Chen, P. Stashenko, and Y.-P. Li
Specificity of RGS10A as a key component in the RANKL signaling mechanism for osteoclast differentiation
J. Cell Sci., October 1, 2007; 120(19): 3362 - 3371.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Kovacic, I. K. Lukic, D. Grcevic, V. Katavic, P. Croucher, and A. Marusic
The Fas/Fas Ligand System Inhibits Differentiation of Murine Osteoblasts but Has a Limited Role in Osteoblast and Osteoclast Apoptosis
J. Immunol., March 15, 2007; 178(6): 3379 - 3389.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Park, Y.-K. Jung, O.-J. Park, Y. J. Lee, J.-Y. Choi, and Y. Choi
Interaction of Fas Ligand and Fas Expressed on Osteoclast Precursors Increases Osteoclastogenesis
J. Immunol., December 1, 2005; 175(11): 7193 - 7201.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Wu, E.-Y. Ahn, M. A. McKenna, H. Yeo, and J. M. McDonald
Fas Binding to Calmodulin Regulates Apoptosis in Osteoclasts
J. Biol. Chem., August 19, 2005; 280(33): 29964 - 29970.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. Zhao, F. P. Ross, and S. L. Teitelbaum
Unoccupied {alpha}v{beta}3 Integrin Regulates Osteoclast Apoptosis by Transmitting a Positive Death Signal
Mol. Endocrinol., March 1, 2005; 19(3): 771 - 780.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. E. De Paepe, Q. Mao, M. Embree-Ku, L. P. Rubin, and F. I. Luks
Fas/FasL-mediated apoptosis in perinatal murine lungs
Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L730 - L742.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society